{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:00:58Z","timestamp":1761102058248},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>Dysphagia is a known complication in Pompe Disease (PD), a severe metabolic myopathy due to alpha-glucosidase deficiency. Enzyme replacement therapy (ERT) with alglucosidase alfa is the only approved therapy for PD. Presently no data are available on the effects of ERT on dysphagia in PD patients. The aim of this work is to evaluate the course of this complication in a 6\u00a0years old boy affected by PD after treatment with ERT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Dysphagia was assessed by Videofluoroscopic Swallowing Study (VFSS) at baseline, before the start of ERT and after 36\u00a0months of therapy. We used the Dysphagia Severity Rating Scale (DSS) to define the severity grade of dysphagia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>VFSS performed at baseline revealed complete incoordination of oral stage swallowing which was classified as a grade 1 dysphagia according to DSS. After 36\u00a0months of treatment VFSS revealed normal swallowing, classified as grade 0 by DSS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results suggest that ERT is effective in improving dysphagia. VFSS may be a useful tool to investigate and monitor swallowing disorders in patients affected by PD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1824-7288-39-30","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T12:14:45Z","timestamp":1368447285000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improvement of dysphagia in a child affected by Pompe disease treated with enzyme replacement therapy"],"prefix":"10.1186","volume":"39","author":[{"given":"Simona","family":"Fecarotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Montefusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Della Casa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Villari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Generoso","family":"Andria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,13]]},"reference":[{"key":"289_CR1","unstructured":"OMIM. [http:\/\/omim.org\/entry\/232300]"},{"key":"289_CR2","first-page":"3389","volume-title":"The Metabolic and Molecular Bases of Inherited Disease. 8th edition","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser AJJ: Glycogen Storage Disease Type II (GSDII). The Metabolic and Molecular Bases of Inherited Disease. 8th edition. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. 2001, NewYork: McGraw-Hill, 3389-420."},{"issue":"6","key":"289_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","volume":"7","author":"MG Ausems","year":"1999","unstructured":"Ausems MG, Verbiest J, Hermans MP, Kroos MA, Beemer FA, Wokke JH, Sandkuijl LA, Reuser AJ, van der Ploeg AT: Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet. 1999, 7 (6): 713-6. 10.1038\/sj.ejhg.5200367.","journal-title":"Eur J Hum Genet"},{"key":"289_CR4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT van der Ploeg","year":"2008","unstructured":"van der Ploeg AT, JReuser AJ: Pompe\u2019s disease. Lancet. 2008, 372: 1342-53. 10.1016\/S0140-6736(08)61555-X.","journal-title":"Lancet"},{"key":"289_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM Van den Hout","year":"2003","unstructured":"Van den Hout HM, Hop W, Van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, De Klerk JB, Reuser AJ, van der Ploeg AT: The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003, 112: 332-340. 10.1542\/peds.112.2.332.","journal-title":"Pediatrics"},{"key":"289_CR6","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","volume":"64","author":"ML Hagemans","year":"2005","unstructured":"Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT: Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology. 2005, 64: 2139-2141. 10.1212\/01.WNL.0000165979.46537.56.","journal-title":"Neurology"},{"issue":"5","key":"289_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D: Infantile-Onset Pompe Disease Natural History Study Group. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. JPediatr. 2006, 148 (5): 671-676. 10.1016\/j.jpeds.2005.11.033.","journal-title":"JPediatr"},{"issue":"8","key":"289_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","volume":"252","author":"LP Winkel","year":"2005","unstructured":"Winkel LP, Hagemans ML, Van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, van der Ploeg AT: The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol. 2005, 252 (8): 875-84. 10.1007\/s00415-005-0922-9.","journal-title":"J Neurol"},{"issue":"23 Suppl 2","key":"289_CR9","first-page":"S12-36","volume":"71","author":"B Bembi","year":"2008","unstructured":"Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, Musumeci O, Parenti G, Ravaglia S, Seidita F, Toscano A, Vianello A: Management and treatment of glycogenosistype I. Neurology. 2008, 71 (23 Suppl 2): S12-36-","journal-title":"Neurology"},{"issue":"23 Suppl 2","key":"289_CR10","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","volume":"71","author":"B Bembi","year":"2008","unstructured":"Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, Musumeci O, Parenti G, Ravaglia S, Seidita F, Toscano A, Vianello A: Diagnosis of glycogenosis type II. Neurology. 2008, 71 (23 Suppl 2): S4-11.","journal-title":"Neurology"},{"key":"289_CR11","first-page":"132","volume":"3","author":"A Amalfitano","year":"2001","unstructured":"Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, Mackey J, Kishnani P, Smith W, McVie-Wylie A, Sullivan JA, Hoganson GE, Phillips JA, Schaefer GB, Charrow J, Ware RE, Bossen EH, Chen YT: Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial. Genet Med. 2001, 3: 132-138.","journal-title":"Genet Med"},{"issue":"1","key":"289_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","volume":"15","author":"L Klinge","year":"2005","unstructured":"Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, G\u00f6rlinger K, Wallot M, Richards S, Voit T: Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord. 2005, 15 (1): 24-31. 10.1016\/j.nmd.2004.10.009.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"289_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","volume":"149","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Nicolino M, Voit T, Rogers RC, Tsai AC, Waterson J, Herman GE Amalfitano A, Thurberg BL, Richards S, Davison M, Corzo D, Chen YT: Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr. 2006, 149 (1): 89-97. 10.1016\/j.jpeds.2006.02.035.","journal-title":"J Pediatr"},{"key":"289_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, De la Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE: Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology. 2007, 68: 88-89. 10.1212\/01.wnl.0000253226.13795.40.","journal-title":"Neurology"},{"issue":"9","key":"289_CR15","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/gim.2012.44","volume":"14","author":"SN Prater","year":"2012","unstructured":"Prater SN, Banugaria SG, DeArmey SM, Botha EG, Stege EM, Case LE, Jones HN, Phornphutkul C, Wang RY, Young SP, Kishnani PS: The emerging phenotype of long-term survivors with infantile Pompe disease. Genet Med. 2012, 14 (9): 800-10. 10.1038\/gim.2012.44.","journal-title":"Genet Med"},{"issue":"5","key":"289_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10545-010-9144-0","volume":"33","author":"CI Van Capelle","year":"2010","unstructured":"Van Capelle CI, Goedegebure A, Homans NC, Hoeve HL, Reuser AJ, van der Ploeg AT: Hearing loss in Pompe disease revisited: results from a study of 24 children. J Inherit Metab Dis. 2010, 33 (5): 597-602. 10.1007\/s10545-010-9144-0.","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"289_CR17","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1007\/s00415-010-5618-0","volume":"257","author":"S Sacconi","year":"2010","unstructured":"Sacconi S, Bocquet JD, Chanalet S, Tanant V, Salviati L, Desnuelle C: Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol. 2010, 257 (10): 1730-3. 10.1007\/s00415-010-5618-0.","journal-title":"J Neurol"},{"issue":"3","key":"289_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","volume":"47","author":"LE van den Berg","year":"2010","unstructured":"van den Berg LE, Zandbergen AA, Van Capelle CI, De Vries JM, Hop WC, van den Hout JM, Reuser AJ, Zillikens MC, van der Ploeg AT: Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density. Bone. 2010, 47 (3): 643-9. 10.1016\/j.bone.2010.06.021.","journal-title":"Bone"},{"issue":"6","key":"289_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138920111795542606","volume":"12","author":"G Parenti","year":"2011","unstructured":"Parenti G, Andria G: Pompe disease: from new views on pathophysiology to innovative therapeutic strategies. Curr Pharm Biotechnol. 2011, 12 (6): 15-902.","journal-title":"Curr Pharm Biotechnol"},{"key":"289_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00455-009-9252-x","volume":"25","author":"HN Jones","year":"2010","unstructured":"Jones HN, Muller CW, Lin M, Banugaria SG, Case LE, Li JS, O\u2019Grady G, Heller JH, Kishnani PS: Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease. Dysphagia. 2010, 25: 277-283. 10.1007\/s00455-009-9252-x.","journal-title":"Dysphagia"},{"issue":"3","key":"289_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","volume":"35","author":"CM Van Gelder","year":"2012","unstructured":"Van Gelder CM, Van Capelle CI, Ebbink BJ, Moor-van Nugteren I, van den Hout JM, Hakkesteegt MM, Van Doorn PA, De Coo IF, Reuser AJ, De Gier HH, van der Ploeg AT: Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy. J Inherit Metab Dis. 2012, 35 (3): 505-11. 10.1007\/s10545-011-9404-7.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"289_CR22","first-page":"319","volume":"23","author":"LD Hobson-Webb","year":"2013","unstructured":"Hobson-Webb LD, Jones HN, Kishnani PS: Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement. NeuromusculDisord. 2013, 23 (4): 319-323. Jan 15","journal-title":"NeuromusculDisord"},{"issue":"9","key":"289_CR23","first-page":"911","volume":"36","author":"MP Hiorns","year":"2006","unstructured":"Hiorns MP, Ryan MM: Current practice in paediatric videofluoroscopy. PediatrRadiol. 2006, 36 (9): 911-9.","journal-title":"PediatrRadiol"},{"issue":"1","key":"289_CR24","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1148\/rg.e22","volume":"26","author":"J Gates","year":"2006","unstructured":"Gates J, Hartnell GG, Gramigna GD: Videofluoroscopy and swallowing studies for neurologic disease: a primer. RadioGraphics. 2006, 26 (1): e22-10.1148\/rg.e22.","journal-title":"RadioGraphics"},{"issue":"4","key":"289_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3148\/67.4.2006.185","volume":"67","author":"S Williams","year":"2006","unstructured":"Williams S, Witherspoon K, Kavsak P, Patterson C, McBlain J: Pediatric feeding and swallowing problems: an interdisciplinary team approach. Can J Diet Pract Res. 2006, 67 (4): 185-90. 10.3148\/67.4.2006.185.","journal-title":"Can J Diet Pract Res"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1824-7288-39-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:09:45Z","timestamp":1630541385000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/1824-7288-39-30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1186\/1824-7288-39-30","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,13]]},"assertion":[{"value":"18 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"30"}}